1WTH image
Deposition Date 2004-11-23
Release Date 2005-03-08
Last Version Date 2023-10-25
Entry Detail
PDB ID:
1WTH
Title:
Crystal structure of gp5-S351L mutant and gp27 complex
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.28
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
H 3 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Tail-associated lysozyme
Gene (Uniprot):5
Mutagens:S351L
Chain IDs:A
Chain Length:584
Number of Molecules:1
Biological Source:Enterobacteria phage T4
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Baseplate structural protein Gp27
Gene (Uniprot):27
Chain IDs:B (auth: D)
Chain Length:391
Number of Molecules:1
Biological Source:Enterobacteria phage T4
Primary Citation
Control of bacteriophage t4 tail lysozyme activity during the infection process
J.Mol.Biol. 346 1013 1020 (2005)
PMID: 15701513 DOI: 10.1016/j.jmb.2004.12.042

Abstact

Bacteriophage T4 has an efficient mechanism for injecting the host Escherichiacoli cell with genomic DNA. Its gene product 5 (gp5) has a needle-like structure attached to the end of a tube through which the DNA passes on its way out of the head and into the host. The gp5 needle punctures the outer cell membrane and then digests the peptidoglycan cell wall in the periplasmic space. gp5 is normally post-translationally cleaved between residues 351 and 352. The function of this process in controlling the lysozyme activity of gp5 has now been investigated. When gp5 is over-expressed in E.coli, two mutants (S351H and S351A) showed a reduction of cleavage products and five other mutants (S351L, S351K, S351Y, S351Q, and S351T) showed no cleavage. Furthermore, in a complementation assay at 20 degrees C, the mutants that had no cleavage of gp5 produced a reduced number of plaques compared to wild-type T4. The crystal structure of the non-cleavage phenotype mutant of gp5, S351L, complexed with gene product 27, showed that the 18 residues in the vicinity of the potential cleavage site (disordered in the wild-type structure) had visible electron density. The polypeptide around the potential cleavage site is exposed, thus allowing access for an E.coli protease. The lysozyme activity is inhibited in the wild-type structure by a loop from the adjacent gp5 monomer that binds into the substrate-binding site. The same inhibition is apparent in the mutant structure, showing that the lysozyme is inhibited before gp5 is cleaved and, presumably, the lysozyme is activated only after gp5 has penetrated the outer membrane.

Legend

Protein

Chemical

Disease

Primary Citation of related structures